1. Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;3;179(2):312-39. doi.org/10.1016/j.cell.2019.09.001. [DOI:10.1016/j.cell.2019.09.001]

2. Xu K, Wang M, Zhou W, Pu J, Wang H, Xie P. Chronic D-ribose and D-mannose overload induce depressive/anxiety-like behavior and spatial memory impairment in mice. Transl Psychiatry. 2021;11(1):90. doi:10.1038/s41398-021-01456-3. [DOI:10.1038/s41398-020-01126-4]

3. Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (Transl Res Clin Interv). 2018;4:575-90. doi:10.1016/j.trci.2018.06.001. [DOI:10.1016/j.trci.2018.06.001]

4. Rao YL, Ganaraja B, Suresh PK, Joy T, Ullal SD, Manjrekar PA, et al. Effect of resveratrol and combination of resveratrol and donepezil on the expression of microglial cells and astrocytes in Wistar albino rats of colchicine-induced Alzheimer's disease. 3 Biotech. 2023;13(9):1-14. doi:10.1007/s13205-023-03539-2. [DOI:10.1007/s13205-023-03743-4]

5. Hirata Y, Tsunekawa Y, Takahashi M, Oh-Hashi K, Kawaguchi K, Hayazaki M, et al. Identification of novel neuroprotective N, N-dimethylaniline derivatives that prevent oxytosis/ferroptosis and localize to late endosomes and lysosomes. Free Radic Biol Med. 2021;174:225-35. doi:10.1016/j.freeradbiomed.2021.09.015. [DOI:10.1016/j.freeradbiomed.2021.09.015]

6. Zhang X, Jiang L, Chen H, Wei S, Yao K, Sun X, et al. Resveratrol protected acrolein-induced ferroptosis and insulin secretion dysfunction via ER-stress-related PERK pathway in MIN6 cells. Toxicology. 2022;465:153048. doi:10.1016/j.tox.2022.153048. [DOI:10.1016/j.tox.2021.153048]

7. Li S, He Y, Chen K, Sun J, Zhang L, He Y, et al. RSL3 drives ferroptosis through NF-κB pathway activation and GPX4 depletion in glioblastoma. Oxid Med Cell Longev. 2021;2021:7420187. doi:10.1155/2021/7420187. [DOI:10.1155/2021/2915019]

8. Wu S, Zhang Y, Kou X. Treadmill exercise improves cognitive dysfunction in diabetic rats. Chin J Tissue Eng Res. 2023;27(2):208. doi:10.3969/j.issn.2095-4348.2023.02.015.

9. Kim TH, Chang JS, Park K-S, Park J, Kim N, Lee JI, et al. Effects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: A pilot single-blind randomized controlled trial. PLoS One. 2017;12(2):e0171771. doi:10.1371/journal.pone.0171771. [DOI:10.1371/journal.pone.0171771]

10. Shan X, Lv S, Huang P, Zhang W, Jin C, Liu Y, et al. Classic famous prescription kai-xin-san ameliorates Alzheimer's disease via the Wnt/β-catenin signaling pathway. Mol Neurobiol. 2023:1-16. doi:10.1007/s12035-023-03528-2. [DOI:10.1007/s12035-023-03707-y]

11. Fisher E, Wood SJ, Elsworthy RJ, Upthegrove R, Aldred S. Exercise as a protective mechanism against the negative effects of oxidative stress in first-episode psychosis: a biomarker-led study. Transl Psychiatry. 2020;10(1):254. doi:10.1038/s41398-020-00877-6. [DOI:10.1038/s41398-020-00927-x]

12. Chiang M-C, Nicol CJ, Cheng Y-C. Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress. Neurochem Int. 2018;115:1-10. doi:10.1016/j.neuint.2017.11.003. [DOI:10.1016/j.neuint.2017.11.003]

13. Seyyedsalehi MS, Saboor-Yaraghi AA, Koohdani F, Amiri F, Norouzzadeh M, Kalikias Y, Talebi S, Pasalar P, Berahmeh A, Shemirani F, Mahmoodi M. Resveratrol affects β-catenin and GSK-3β gene expression in Wnt-signalingpathway in HCT-116 human colorectal cancer cells. Basic & Clinical Cancer Research. 2018;30;10(1):22-33. bccr.tums.ac.ir/index.php/bccrj/article/view/272

14. Dong Y, Wang Z, Yan Z, Wu C, Yang T, Qiu H. Neuroprotective effects of resveratrol on a mouse model of Parkinson's disease via the Wnt/Beta-Catenin signaling pathway. Indian J Pharm Sci. 2022;84:959. doi:10.36468/pharmaceutical-sciences.736. [DOI:10.36468/pharmaceutical-sciences.736]

15. Eslimiesfahani D, Oryan S, Khosravi M, Valizadegan F. Effect of fennel extract on the improvement of memory disorders in beta amyloid alzheimer model of male wistar rats. J. Ilam Uni. Med. Sci. 2019; 27 (1) :1-12. doi: 10.29252/sjimu.27.1.1 [DOI:10.29252/sjimu.27.1.1]

16. Wu C, Yang L, Li Y, Dong YA, Yang B, Tucker LD, Zong X, Zhang Q. Effects of exercise training on anxious-depressive-like behavior in Alzheimer rat. Medicine and science in sports and exercise. 2020;52(7):1456. doi:10.1249/MSS.0000000000002294. [DOI:10.1249/MSS.0000000000002294]

17. Monserrat Hernández‐Hernández E, Serrano‐García C, Antonio Vázquez‐Roque R, Díaz A, Monroy E, Rodríguez‐Moreno A, et al. Chronic administration of resveratrol prevents morphological changes in prefrontal cortex and hippocampus of aged rats. Synapse. 2016;70(5):206-17. doi:10.1002/syn.21884. [DOI:10.1002/syn.21884]

18. Liu J, Wei AH, Liu TT, Ji XH, Zhang Y, Yan F, et al. Icariin ameliorates glycolytic dysfunction in Alzheimer's disease models by activating the Wnt/β‐catenin signaling pathway. FEBS J. 2024. doi:10.1111/febs.17055. [DOI:10.1111/febs.17055]

19. García-Velázquez L, Arias C. The emerging role of Wnt signaling dysregulation in the understanding and modification of age-associated diseases. Ageing Res Rev. 2017;37:135-45. doi:10.1016/j.arr.2017.07.001. [DOI:10.1016/j.arr.2017.07.001]

20. Harris RA, Tindale L, Cumming RC. Age-dependent metabolic dysregulation in cancer and Alzheimer's disease. Biogerontology. 2014;15:559-77. doi:10.1007/s10522-014-9501-x. [DOI:10.1007/s10522-014-9534-z]

21. Chen D, Zhang Y, Zhang M, Chang J, Zeng Z, Kou X, et al. Exercise attenuates brain aging by rescuing down-regulated Wnt/β-catenin signaling in aged rats. Front Aging Neurosci. 2020;12:105. doi:10.3389/fnagi.2020.00105. [DOI:10.3389/fnagi.2020.00105]

22. Zanjanian S, Kordi MR, Ravasi AA. Comparison of the effect of voluntary exercise in enriched environment and forced exercise on Wnt-5a expression and Amyloid Beta accumulation in hippocampus of rats with type 3 diabetes. Daneshvar Med. 2023;30(5):62-78.

23. Xiao HH, Chen JC, Li H, Li RH, Wang HB, Song HP, et al. Icarisid II rescues cognitive dysfunction via activation of Wnt/β‐catenin signaling pathway promoting hippocampal neurogenesis in APP/PS1 transgenic mice. Phytother Res. 2022;36(5):2095-108. doi:10.1002/ptr.7480. [DOI:10.1002/ptr.7480]

24. Kim D-Y, Jung S-Y, Kim K, Kim C-J. Treadmill exercise ameliorates Alzheimer disease-associated memory loss through the Wnt signaling pathway in the streptozotocin-induced diabetic rats. J Exerc Rehabil. 2016;12(4):276. doi:10.12965/jer.1632744.355. [DOI:10.12965/jer.1632678.339]

25. Khrimian L, Obri A, Ramos-Brossier M, Rousseaud A, Moriceau S, Nicot AS, Mera P, Kosmidis S, Karnavas T, Saudou F, Gao XB. Gpr158 mediates osteocalcin's regulation of cognition. Journal of Experimental Medicine. 2017;214(10):2859-73. doi.org/10.1084/jem.20171320 [DOI:10.1084/jem.20171320]

26. Ghari M, Fathi E, Farahzadi R. The role of Wnt/β-catenin signaling pathway in blood leukemias. Scientific Journal of Iran Blood Transfus Organ. 2018;15(2):149-64. http://bloodjournal.ir/article-1-1156-en.html.

27. Gardinier JD, Rostami N, Juliano L, Zhang C. Bone adaptation in response to treadmill exercise in young and adult mice. Bone Rep. 2018;8:29-37. doi:10.1016/j.bonr.2018.01.004. [DOI:10.1016/j.bonr.2018.01.004]

28. Xiang T, Zhang S, Cheng N, Ge S, Wen J, Xiao J, et al. Oxidored-nitro domain-containing protein 1 promotes liver fibrosis by activating the Wnt/β-catenin signaling pathway in vitro. Mol Med Rep. 2017;16(4):5050-4. doi:10.3892/mmr.2017.7054. [DOI:10.3892/mmr.2017.7054]

29. Aghaizu ND, Jin H, Whiting PJ. Dysregulated Wnt signalling in the Alzheimer's brain. Brain Sciences. 2020;10(12):902. doi.org/10.3390/brainsci10120902. [DOI:10.3390/brainsci10120902]

30. Kang J, Liu M, Yang Q, Dang X, Li Q, Wang T, Qiu B, Zhang Y, Guo X, Li X, Liu Y. Exercise training exerts beneficial effects on Alzheimer's disease through multiple signaling pathways. Frontiers in Aging Neuroscience. 2025;17:1558078. doi.org/10.3389/fnagi.2025.1558078. [DOI:10.3389/fnagi.2025.1558078]

31. Tong XK, Royea J, Hamel E. Simvastatin rescues memory and granule cell maturation through the Wnt/β-catenin signaling pathway in a mouse model of Alzheimer's disease. Cell death & disease. 2022;13(4):325. https://doi.org/10.1038/s41419-022-04784-y [DOI:10.1038/s41419-022-04784-y.]

32. Surya K, Manickam N, Jayachandran KS, Kandasamy M, Anusuyadevi M. Resveratrol mediated regulation of hippocampal neuroregenerative plasticity via SIRT1 pathway in synergy with Wnt signaling: Neurotherapeutic implications to mitigate memory loss in Alzheimer's disease. J Alzheimers Dis. 2023;94(s1):S125-S40. doi:10.3233/JAD-220418. [DOI:10.3233/JAD-220418]

33. Yang X-H, Song S-Q, Xu Y. Resveratrol ameliorates chronic unpredictable mild stress-induced depression-like behavior: involvement of the HPA axis, inflammatory markers, BDNF, and Wnt/β-catenin pathway in rats. Neuropsychiatr Dis Treat. 2017:2727-36. doi:10.2147/NDT.S147724. [DOI:10.2147/NDT.S150028]

34. Yang X, Xu S, Qian Y, Xiao Q. Resveratrol regulates microglia M1/M2 polarization via PGC-1α in conditions of neuroinflammatory injury. Brain Behav Immun. 2017;64:162-72. doi:10.1016/j.bbi.2017.02.014. [DOI:10.1016/j.bbi.2017.02.014]

35. Hoda U, Agarwal NB, Vohora D, Parvez S, Raisuddin S. Resveratrol suppressed seizures by attenuating IL-1β, IL1-Ra, IL-6, and TNF-α in the hippocampus and cortex of kindled mice. Nutr Neurosci. 2017;20(9):497-504. doi:10.1080/1028415X.2017.1299465. [DOI:10.1080/1028415X.2016.1189057]

36. Holloway KR, Calhoun TN, Saxena M, Metoyer CF, Kandler EF, Rivera CA, et al. SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling. Proc Natl Acad Sci U S A. 2010;107(20):9216-21. doi:10.1073/pnas.1002787107. [DOI:10.1073/pnas.0911325107]

37. Hussain M, Rao M, Humphries AE, Hong JA, Liu F, Yang M, et al. Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells. Cancer Res. 2009;69(8):3570-8. doi:10.1158/0008-5472.CAN-08-2726. [DOI:10.1158/0008-5472.CAN-08-2807]

38. Broderick TL, Rasool S, Li R, Zhang Y, Anderson M, Al-Nakkash L, et al. Neuroprotective effects of chronic resveratrol treatment and exercise training in the 3xTg-AD mouse model of Alzheimer's disease. Int J Mol Sci. 2020;21(19):7337. doi:10.3390/ijms21197337. [DOI:10.3390/ijms21197337]

39. Liao Z-Y, Chen J-L, Xiao M-H, Sun Y, Zhao Y-X, Pu D, et al. The effect of exercise, resveratrol or their combination on Sarcopenia in aged rats via regulation of AMPK/Sirt1 pathway. Exp Gerontol. 2017;98:177-83. doi:10.1016/j.exger.2017.08.004. [DOI:10.1016/j.exger.2017.08.004]

40. Ren J, Xiao H. Exercise intervention for Alzheimer's disease: unraveling neurobiological mechanisms and assessing effects. Life. 2023;13(12):2285. doi.org/10.3390/life13122285. [DOI:10.3390/life13122285]

41. Cantón-Suárez A, Sánchez-Valdeón L, Bello-Corral L, Cuevas MJ, Estébanez B. Understanding the molecular impact of physical exercise on Alzheimer's disease. International Journal of Molecular Sciences. 2024;25(24):13576. doi.org/10.3390/ijms252413576. [DOI:10.3390/ijms252413576]

42. Choi SH, Bylykbashi E, Chatila ZK, Lee SW, Pulli B, Clemenson GD, Kim E, Rompala A, Oram MK, Asselin C, Aronson J. Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer's mouse model. Science. 2018;361(6406):eaan8821. doi: 10.1126/science.aan8821. [DOI:10.1126/science.aan8821]

43. AlHayani DA, Kubaev A, Uthirapathy S, Mandaliya V, Ballal S, Kalia R, Arya R, Gabble BC, Alasheqi MQ, Kadhim AJ. Insights Into the Therapeutic Potential of SIRT1-modifying Compounds for Alzheimer's Disease: A Focus on Molecular Mechanisms. Journal of Molecular Neuroscience. 2025;75(1):29. doi.org/10.1007/s12031-025-02324-9. [DOI:10.1007/s12031-025-02324-9]

44. Cao W, Li H, Fan K, Tuya W. Respiratory Syncytial Virus Enhances SIRT2 Expression Through Wnt/?-Catenin Signaling to Promote Lung Cancer Progression. Jundishapur Journal of Microbiology. 2025;18(5):1-3. doi.org/10.5812/jjm-158800. [DOI:10.5812/jjm-158800]

45. Padmakumar S, Taha MS, Kadakia E, Bleier BS, Amiji MM. Delivery of neurotrophic factors in the treatment of age-related chronic neurodegenerative diseases. Expert opinion on drug delivery. 2020;17(3):323-40. doi.org/10.1080/17425247.2020.1727443. [DOI:10.1080/17425247.2020.1727443]